PMA device
Exablate 4000 (Neuro) Type 1.0 & 1.1
Insightec · Mr-Guided Focused Ultrasound System (POH, Class III) · First FDA decision Nov 9, 2020, newest Nov 9, 2020Essential tremorParkinson's disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
25
Naming "Exablate 4000 Type"
MAUDE reports
0
Brand "Exablate 4000 Type", since 2015
PubMed studies
0
Mentioning "Exablate 4000 Type"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Exablate 4000 (Neuro) Type 1.0 & 1.1
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Exablate 4000 (Neuro) Type 1.0 & 1.1PMA supplement
P150038-S010 · Decided Nov 9, 2020 · 647 days after receipt · Normal 180 Day Track No User Fee
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for TremorProposed local determinationProposedDL37421National Government Services, Inc.Updated Sep 18, 2025
- Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's DiseaseLocal determinationIn effectL37729Noridian Healthcare Solutions, LLCUpdated Sep 2, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Exablate 4000 Type", any status and sponsor, newest update first.
Children's National Research InstituteAcademic, hospital or other
NCT07796061 · 45 participants (planned) · Start Dec 2026 · Primary completion Dec 2031
Device: BBB Disruption · For: DMG; DIPG
Sites: Washington D.C., District of Columbia
- Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain MetsPivotal-lookingRecruiting
InSightecNot on our public-company list
NCT05317858 · 96 participants (planned) · Start Aug 12, 2022 · Primary completion Jun 1, 2031
Device: Blood Brain Barrier Opening - Oncology · For: Brain Tumor; Non Small Cell Lung Cancer
Sites: Phoenix, Arizona; Newport Beach, California; Fort Lauderdale, Florida · 16 sites in all
Mayo ClinicAcademic, hospital or other
NCT05733312 · 6 participants (planned) · Start Jan 24, 2024 · Primary completion Jan 15, 2027
Device: InSightec's ExAblate Neuro Model 4000 Type 2.0 (220 KHz) system · For: Brain Tumor
Sites: Rochester, Minnesota
22 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Exablate 4000 Type", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code POH
262 reports: 2 malfunction, 254 injury, 5 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Exablate 4000 Type"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code POH.
- Exablate Model 4000 SystemInsightec · PMA 2026
- Exablate 4000 System Type-1 (i.e. Type 1.0/1.1)Insightec · PMA 2022
- ExAblate Neuro ThalamotomyInsightec · PMA 2017
- Exablate NeuroInsightec · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.